Shopping Cart
- Remove All
- Your shopping cart is currently empty
LY2940094 (LY-2940094) decreases ethanol self-administration in animal models. LY2940094 is an effective, selective, and orally available nociceptin receptor antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $74 | In Stock | |
2 mg | $108 | In Stock | |
5 mg | $166 | In Stock | |
10 mg | $288 | In Stock | |
25 mg | $571 | In Stock | |
50 mg | $819 | In Stock | |
100 mg | $1,130 | In Stock | |
1 mL x 10 mM (in DMSO) | $189 | In Stock |
Description | LY2940094 (LY-2940094) decreases ethanol self-administration in animal models. LY2940094 is an effective, selective, and orally available nociceptin receptor antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). |
Targets&IC50 | NOP receptor: 0.166 nM(Kb), NOP receptor:(ki)0.105 nM |
In vivo | In Indiana Alcohol-Preferring (P) and Marchigian Sardinian Alcohol-Preferring (msP) rats, LY-2940094 (3, 10, or 30 mg/kg; 2-3 mL/kg; orally daily; for 4 days) dose-dependently decreases homecage ethanol self-administration, without affecting food/water intake or locomotor activity. |
Alias | LY-2940094 |
Molecular Weight | 480.96 |
Formula | C22H23ClF2N4O2S |
Cas No. | 1307245-86-8 |
Smiles | Cc1nn(cc1CN1CCC2(CC1)OCC(F)(F)c1cc(Cl)sc21)-c1ncccc1CO |
Relative Density. | 1.51 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 41.67 mg/mL (86.64 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.